Basic info
Industry
biotechnology
Sectors
Pharmaceutical
Biotechnology
liver based genetic diseases
Biotech
Cell therapy
Fatty liver
Clinical stage
Antibodies
ACLF
Therapeutics
NASH
Liver diseases
Regenerative medicine
Chronic liver disease
Acquired liver diseases
Acute liver disease
Date founded
2009
Funding rounds raised
Total raised
$31M
from 13 investors over 13 rounds
P
Promethera Biosciences raised $8.4M on December 16, 2019
Investors: Sony Innovation Fund and Pegasus Tech Ventures
P
Promethera Biosciences raised $11M on October 27, 2016
Investors: -, SRIW, FundPlus and Vesalius Biocapital
P
Promethera Biosciences raised $31M on November 25, 2014
Investors: Shire Pharmaceuticals and SFPI-FPIM
P
Promethera Biosciences raised $31M on March 28, 2012
Investors: Shire Pharmaceuticals
P
Promethera Biosciences raised $7.3M on February 2, 2010
Investors: SRIW, -, EQT Life Sciences and Vesalius Biocapital